Minerva Surgical (NASDAQ:UTRS) Trading Down 8.9%

Shares of Minerva Surgical, Inc. (NASDAQ:UTRS) traded down 8.9% during mid-day trading on Wednesday . The company traded as low as $0.51 and last traded at $0.51. 600 shares changed hands during trading, a decline of 84% from the average session volume of 3,772 shares. The stock had previously closed at $0.56.

Minerva Surgical Stock Performance

The business’s fifty day simple moving average is $0.61 and its 200-day simple moving average is $1.47. The company has a current ratio of 1.88, a quick ratio of 1.03 and a debt-to-equity ratio of 1.38.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. State Street Corp increased its holdings in shares of Minerva Surgical by 950.6% in the second quarter. State Street Corp now owns 161,800 shares of the company’s stock worth $41,000 after purchasing an additional 146,400 shares during the period. Geode Capital Management LLC increased its holdings in shares of Minerva Surgical by 284.7% in the second quarter. Geode Capital Management LLC now owns 128,749 shares of the company’s stock worth $33,000 after purchasing an additional 95,284 shares during the period. Finally, Vanguard Group Inc. increased its holdings in shares of Minerva Surgical by 64.8% in the first quarter. Vanguard Group Inc. now owns 378,781 shares of the company’s stock worth $1,705,000 after purchasing an additional 148,915 shares during the period.

Minerva Surgical Company Profile

Minerva Surgical, Inc, a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps.